Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05183087 · ClinicalTrials.gov registry record
Long-Term Effects of Repetitive, Low-Level Blast Exposure on Special Operations Forces Service Members
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 30
- Enrollment target
NCT05183087: Completed study, sponsored by Massachusetts General Hospital.
NCT05183087 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05183087 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This is a pilot study to identify biomarkers that individually, and in combination, demonstrate the greatest sensitivity to repetitive, low-level blast exposure (RLLBE) neurotrauma in Special Operations Forces (SOF) personnel. The proposed cross-sectional, multimodal study will elucidate the potential effects of long-term RLLBE by comparing biomarkers across subjects.
Primary Outcome
measured by white matter tractography
Interventions
- DIAGNOSTIC_TEST 3T Connectome MRI
- DIAGNOSTIC_TEST 7 Tesla MRI
- DIAGNOSTIC_TEST TSPO PET
- DIAGNOSTIC_TEST Tau PET
- DIAGNOSTIC_TEST Cognitive and Behavioral Assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2023-02-28 |
What the finished NCT05183087 record still lists
NCT05183087 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which 3T Connectome MRI is the first listed.
NCT05183087 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05183087 about?
NCT05183087 is a clinical study titled "Long-Term Effects of Repetitive, Low-Level Blast Exposure on Special Operations Forces Service Members". This is a pilot study to identify biomarkers that individually, and in combination, demonstrate the greatest sensitivity to repetitive, low-level blast exposure (RLLBE) neurotrauma in Special Operations Forces (SOF) personnel. The proposed cross-sectional, multimodal study will elucidate the potenti...
What is the current status of trial NCT05183087?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2021-07-01. Estimated completion is 2023-02-28.
What interventions are being tested in trial NCT05183087?
The interventions under investigation include: 3T Connectome MRI (DIAGNOSTIC_TEST), 7 Tesla MRI (DIAGNOSTIC_TEST), TSPO PET (DIAGNOSTIC_TEST), Tau PET (DIAGNOSTIC_TEST), Cognitive and Behavioral Assessments (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05183087?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI